Skip to content

Study on the theory and method of TDCS in improving cognitive function of early AD patients

Study on the theory and method of TDCS in improving cognitive function of early AD patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036603
Enrollment
Unknown
Registered
2020-08-24
Start date
2017-01-03
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive impairment

Interventions

Experimental group:TDCS stimulates the left prefrontal lobe
control group:Sham stimulation of left prefrontal lobe

Sponsors

Department of Neurology, the First Affiliated Hospital of the Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 55 to 85 years; 2. Those diagnosed as early AD met CCMD-3, ad diagnostic criteria; 3. Cooperate with the clinical trial and sign the informed consent form; 4. Patients with denture and pacemaker were excluded; 5. According to the classification standard of dementia, the patients were diagnosed as suspicious and mild dementia according to the CDR grading standard (0.5-1.0).

Exclusion criteria

Exclusion criteria: 1. Sudden and apoplectic onset; 2. Local neurological signs (hemiplegia, sensory disturbance and visual field defect) occurred in the early stage of the disease, or epilepsy or abnormal gait occurred in the early stage of the disease; 3. Dementia and mental illness caused by systemic diseases (depression, schizophrenia, etc.).

Design outcomes

Primary

MeasureTime frame
MMSE;fMRI;

Secondary

MeasureTime frame
Moca;ADL;HRQoL;

Countries

China

Contacts

Public ContactJue Wang

College of Life Science and Technology, Xi'an Jiaotong University

juewang0529@qq.com+86 15332479788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026